TESARO, Roche to evaluate triplet therapy for ovarian cancer

Drug Discovery |  News | 0 Comment | 06 Jun, 2018

Singapore-  TESARO, an oncology-focused biopharmaceutical company, announced that it has entered into a clinical co...Read more

USFDA grants Priority Review to Astellas's NDA for Gilteritinib

Drug Discovery |  News | 0 Comment | 05 Jun, 2018

Japan’s Astellas Pharma recently announced that the U.S. Food and Drug Administration (FDA) has accepted, with Pri...Read more

Versartis, Aravive enter into merger agreement

Drug Discovery |  News | 0 Comment | 04 Jun, 2018

Singapore- Versartis and Aravive Biologics jointly announced that they have entered into a definitive agreement under wh...Read more

Blueprint inks deal on oncology therapies with CStone

Drug Discovery |  News | 0 Comment | 04 Jun, 2018

Singapore- Blueprint Medicines and CStone Pharmaceuticals, a privately-held biopharmaceutical company announce an e...Read more

Lilly and Incyte's drug gets FDA approval

Drug Discovery |  News | 0 Comment | 04 Jun, 2018

Singapore- Eli Lilly and Company and Incyte Corporation announced that the U.S. Food and Drug Administration (FDA) has a...Read more

Amgen’s Biosimilar fails to get FDA approval

Drug Discovery |  News | 0 Comment | 04 Jun, 2018

Singapore- Amgen, in a two-sentence announcement, said it received a complete response letter for the biosimilar of Roch...Read more

EC approves Roche’s Perjeta for HER2-positive early breast cancer

Drug Discovery |  News | 0 Comment | 03 Jun, 2018

Global drug giant, Roche recently announced that the European Commission has approved Perjeta (pertuzumab) in combinatio...Read more

LUYE pharma Joins US Firm to Develop Immuno-oncology Treatments

Drug Discovery |  News | 0 Comment | 29 May, 2018

LUYE PHARMA announced that the Group entered into a collaboration and license agreement with Elpis Biopharm, a Boston-re...Read more

FDA approves BioMarin’s metabolic disorder treatment

Drug Discovery |  News | 0 Comment | 25 May, 2018

Singapore- U.S. regulators approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare...Read more

Eisai, Merck provide Update on sNDA for Lenvatinib

Drug Discovery |  News | 0 Comment | 25 May, 2018

Eisai Inc. and Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that the U.S. Food and Dr...Read more

Celgene, Evotec team up on cancer treatments

Drug Discovery |  News | 0 Comment | 22 May, 2018

Singapore- Celgene and German biotech Evotec AG have inked a long-term strategic drug discovery and development par...Read more

AstraZeneca submits sNDA for Forxiga in Japan

Drug Discovery |  News | 0 Comment | 22 May, 2018

Global drug giant, AstraZeneca has submitted a supplemental new drug application (sNDA) to Japan’s Pharmaceuticals...Read more

Minerva’s drug shows treatment effect in schizophrenia patients

Drug Discovery |  News | 0 Comment | 18 May, 2018

 Singapore- Minerva Neurosciences, a clinical-stage biopharmaceutical company focused on the development of therapi...Read more

Cabometyx gets approval in Europe for first-line kidney cancer

Drug Discovery |  News | 0 Comment | 18 May, 2018

 Singapore- The European Commission (EC) has approved commercialization partner Ipsen's marketing application for C...Read more

Regeneron, Sanofi's drug shows positive effect in lung cancer study

Drug Discovery |  News | 0 Comment | 18 May, 2018

 Singapore- Regeneron Pharmaceuticals and development partner Sanofi announce positive preliminary data from a...Read more

Dicerna’s hyperoxaluria treatment gets orphan status from FDA

Drug Discovery |  News | 0 Comment | 18 May, 2018

 Singapore- Dicerna Pharmaceutical’s drug recently received an orphan drug status designation for i...Read more

FDA approves first non-opioid treatment for opioid withdrawal

Drug Discovery |  News | 0 Comment | 17 May, 2018

Singapore- The U.S. Food and Drug Administration approved privately held US WorldMeds LLC's Lucemyra (lofexidine hydroch...Read more

Daré to merge with Pear Tree Pharma

Drug Discovery |  News | 0 Comment | 08 May, 2018

Singapore– Daré Bioscience, a clinical-stage women’s biopharmaceutical company has agreed t...Read more